Cargando…

Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity

Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Quy, Alex S., Li, Xingjian, Male, Louise, Stankovic, Tatjana, Agathanggelou, Angelo, Fossey, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695678/
https://www.ncbi.nlm.nih.gov/pubmed/33299257
http://dx.doi.org/10.1016/j.tet.2020.131631
_version_ 1783615242017701888
author Quy, Alex S.
Li, Xingjian
Male, Louise
Stankovic, Tatjana
Agathanggelou, Angelo
Fossey, John S.
author_facet Quy, Alex S.
Li, Xingjian
Male, Louise
Stankovic, Tatjana
Agathanggelou, Angelo
Fossey, John S.
author_sort Quy, Alex S.
collection PubMed
description Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A protocol for such additions to parthenolide is outlined herein. Reaction conditions were determined using tulipane as a model Michael acceptor. Subsequently, aniline-containing parthenolide derivatives were prepared under the optimised conditions and single crystal X-ray diffraction structures were resolved for three of the compounds synthesised. The synthesised derivatives, along with compounds resulting from a side reaction, were tested for their in vitro anti-leukaemia activity using the chronic lymphocytic leukaemia (CLL) MEC1 cell line. Computational studies with the 2RAM protein structure suggested that the activity of the derivatives was independent of their in silico ability to dock with the Cys38 residue of NF-κB.
format Online
Article
Text
id pubmed-7695678
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pergamon Press
record_format MEDLINE/PubMed
spelling pubmed-76956782020-12-07 Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity Quy, Alex S. Li, Xingjian Male, Louise Stankovic, Tatjana Agathanggelou, Angelo Fossey, John S. Tetrahedron Article Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A protocol for such additions to parthenolide is outlined herein. Reaction conditions were determined using tulipane as a model Michael acceptor. Subsequently, aniline-containing parthenolide derivatives were prepared under the optimised conditions and single crystal X-ray diffraction structures were resolved for three of the compounds synthesised. The synthesised derivatives, along with compounds resulting from a side reaction, were tested for their in vitro anti-leukaemia activity using the chronic lymphocytic leukaemia (CLL) MEC1 cell line. Computational studies with the 2RAM protein structure suggested that the activity of the derivatives was independent of their in silico ability to dock with the Cys38 residue of NF-κB. Pergamon Press 2020-11-27 /pmc/articles/PMC7695678/ /pubmed/33299257 http://dx.doi.org/10.1016/j.tet.2020.131631 Text en Crown Copyright © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Quy, Alex S.
Li, Xingjian
Male, Louise
Stankovic, Tatjana
Agathanggelou, Angelo
Fossey, John S.
Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title_full Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title_fullStr Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title_full_unstemmed Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title_short Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
title_sort aniline-containing derivatives of parthenolide: synthesis and anti-chronic lymphocytic leukaemia activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695678/
https://www.ncbi.nlm.nih.gov/pubmed/33299257
http://dx.doi.org/10.1016/j.tet.2020.131631
work_keys_str_mv AT quyalexs anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity
AT lixingjian anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity
AT malelouise anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity
AT stankovictatjana anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity
AT agathanggelouangelo anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity
AT fosseyjohns anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity